Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
NCT02293564
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
312
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
Interventions
DRUG:
gevokizumab
Sponsor
XOMA (US) LLC